Image

Low Versus High PEEP in Noninvasive Ventilation for Hypoxemic Respiratory Failure

Recruiting
16 - 85 years of age
Both
Phase N/A

Powered by AI

Overview

Current study aimed to explore the effect of high PEEP during noninvasive ventilation among hypoxemic patients with acute respiratory failure.

Description

This was a 1:1 randomized control trial to explore the effect of high versus low PEEP in noninvasive ventilation hypoxemic patients with acute respiratory failure. Several ICUs in China performed this study. In the high PEEP group, the PEEP maintained at 10-15 cmH2O, the inspiratory pressure maintained at 15-20 cmH2O. In the low PEEP group, the PEEP maintained at 5 cmH2O, the inspiratory pressure maintained at 10-20 cmH2O. The primary outcome was incidence of noninvasive ventilation failrue.

Eligibility

Inclusion Criteria

  • age between 16 and 85 years
  • use of dedicated noninvasive ventilator
  • PaCO2 ≤50 mmHg
  • PaO2/FiO2 ≤300mmHg
  • expectation of noninvasive ventilation >12 hours
  • consciousness (Kelly score ≤3 or GCS≥13)

Exclusion Criteria

  • use of noninvasive ventilation before randomization > 24 hours
  • use of noninvasive ventilation due to heart failure, asthma, acute excerbation of COPD
  • presence of contraindication of noninvasive ventilation such as malformation, rencent pulmonary or esophageal surgery et al.
  • end stage disease (expectation of life < 6 months)
  • pneumothorax
  • noninvasive ventilation intolerance
  • refusal of paticipation
  • pregant woman
  • requirement of emergency intubation

Study details

Noninvasive Ventilation

NCT05193786

Chongqing Medical University

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.